Induction of apoptosis in p53-null HL-60 cells by inhibition of lanosterol 14-α demethylase

Biochimie

Volumn 80, Issue 11, 1998, Pages 887-894

  Martínez Botas, Javier ^a   Ferruelo, Antonio J ^a   Suárez, Yajaira ^a   Gómez Coronado, Diego ^a   Lasunción, Miguel A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Apoptosis; Cell proliferation; Cholesterol synthesis; SKF 104976

Indexed keywords

CELL ENZYME; CHOLESTEROL; DIHYDROLANOSTEROL; ENZYME INHIBITOR; LANOSTEROL; LIPOCORTIN 5; MEVALONIC ACID; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INHIBITION; ISOTOPE LABELING; NONHUMAN;

ANIMALIA;

EID: 0344146478     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)88884-7     Document Type: Article

References (41)

1. [1] Chen H.W., Kandutsch A.A., Waymouth C., Inhibition of cell growth by oxygenated derivatives of cholesterol, Nature 251 (1974) 419-421.
2. [2] Brown M.S., Goldstein J.L., Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol, J. Biol. Chem. 249 (1974) 7306-7314.
3. [3] Schulz S., Buhling F., Ansorge S., Prenylated proteins and lymphocyte proliferation: inhibition by d-limonene related monoterpenes, Eur. J. Immunol. 24 (1994) 301-307.
4. [4] Crick D.C., Andres D.A., Waechter C.J., Geranylgeraniol promotes entry of UT-2 cells into the cell cycle in the absence of mevalonate, Exp. Cell Res. 231 (1997) 302-307.
5. [5] Vogt A., Qian Y., McGuire T.F., Hamilton A.D., Sebti S.M., Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts, Oncogene 13 (1996) 1991-1999.
6. [6] Faust J.R., Dice J.F., Evidence for isopentenyladenine modification on a cell cycle-regulated protein, J. Biol. Chem. 266 (1991) 9961-9970.
7. [7] Langan T.J., Slater M.C., Isoprenoids and astroglial cell cycling: diminished mevalonate availability and inhibition of dolichol-linked glycoprotein synthesis arrest cycling through distinct mechanisms, J. Cell. Physiol. 149 (1991) 284-292.
8. [8] Wejde J., Carlberg M., Hjertman M., Larsson O., Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate, J. Cell. Physiol. 155 (1993) 539-548.
9. [9] Vitols S., Norgren S., Juliusson G., Tatidis L., Luthman H., Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells, Blood 84 (1994) 2689-2698.
10. [10] Chen H.W., Heiniger H.J., Kandutsch A.A., Relationship between sterol synthesis and DNA synthesis in phytohemagglutinin-stimulated mouse lymphocytes, Proc. Natl. Acad. Sci. USA 72 (1975) 1950-1954.
11. [11] Quesney-Huneeus V., Wiley M.H., Siperstein M.D., Essential role for mevalonate synthesis in DNA replication, Proc. Natl. Acad. Sci. USA 76 (1979) 5056-5060.
12. [12] Chakrabarti R., Engleman E.G., Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation, J. Biol. Chem. 266 (1991) 12216-12222.
13. [13] Jakobisiak M., Bruno S., Skierski J.S., Darzynkiewicz Z., Cell cycle-specific effects of lovastatin, Proc. Natl. Acad. Sci. USA 88 (1991) 3628-3632.
14. [14] Corsini A., Mazzotti M., Raiteri M., Soma M.R., Gabbiani G., Fumagalli R., Paoletti R., Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase, Atherosclerosis 101 (1993) 117-125.
15. [15] Martinez-Gonzalez J., Vinals M., Vidal F., Llorente-Cortes V., Badimon L., Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells, Atherosclerosis 135 (1997) 213-223.
16. [16] Raiteri M., Arnaboldi L., McGeady P., Gelb M.H., Verri D., Tagliabue C., Quarato P., Ferraboschi P., Santaniello E., Paoletti R., Fumagalli R., Corsini A., Pharmacological control of the mevalonate pathway: Effect on arterial smooth muscle cell proliferation, J. Pharmacol. Exp. Ther. 281 (1997) 144-1153.
17. [17] Ghosh P.M., Mott G.E., Ghosh-Choudhury N., Radnik R.A., Stapleton M.L., Ghidoni J.J., Kreisberg J.J., Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells, Biochim. Biophys. Acta Mol. Cell Res. 1359 (1997) 13-24.
18. [18] Iimura O., Vrtovsnik F., Terzi F., Friedlander G., HMG-CoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture, Kidney Int. 52 (1997) 962-972.
19. [19] Carrero P., Ortega H., Martínez-Botas J., Gómez-Coronado D., Lasunción M.A., Flavonoid-induced ability of minimally modified low-density lipoproteins to support lymphocyte proliferation, Biochem. Pharmacol. 55 (1998) 1125-1129.
20. [20] Wolf D., Rotter V., Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells, Proc. Natl. Acad. Sci. USA 82 (1985) 790-794.
21. [21] Folch J., Lees M., SloaneStanley G.H., A simple method for the isolation and purification of total lipids from animal tissue, J. Biol. Chem. 226 (1957) 497-509.
22. [22] Palacín M., Lasuncion M.A., Herrera E., Utilization of glucose, alanine, lactate, and glycerol as lipogenic substrates by periuterine adipose tissue in situ in fed and starved rats, J. Lipid Res. 29 (1988) 26-32.
23. [23] Chung B.H., Segrest J.P., Ray M.J., Hokanson J.E., Krauss R.M., Beaudrie K., Cone J.T., Segrest J.P., Albers Methods in Enzymology, vol. 28, Plasma Lipoproteins, part A, Preparation, Structure, and Molecular Biology, in: Segrest J.P., Albers J.J. (Eds.), Academic Press Inc., Orlando, 1986, pp. 181-209.
24. [24] Cuthbert J.A., Lipsky P.E., Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation, J. Biol. Chem. 265 (1990) 18568-18575.
25. [25] Smith C.A., Williams G.T., Kingston R., Jenkinson E.J., Owen J.J.T., Antibody to CD3 T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures, Nature 37 (1989) 191-184.
26. [26] Wyllie A.H., Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation, Nature 284 (1980) 555-556.
27. [27] Vermes Y., Haanen C., Steffens-Nakken H., Reutelingsperger C., A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells usinf fluorescein labelled annexin V, J. Immunol. Methods 184 (1995) 39-51.
28. [28] Zhang G., Gurtu V., Kain S.R., Yan G., Early detection of apoptosis using a fluorescent conjugate of Annexin V, BioTechniques 23 (1997) 525-531.
29. [29] Mayer R.J., Adams J.L., Bossard M.J., Berkhout T.A., Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells, J. Biol. Chem. 266 (1991) 20070-20078.
30. [30] Chen H.W., Leonard D.A., Fischer R.T., Trzaskos J.M., A mammalian mutant cell lacking detectable lanosterol 14 alpha-methyl demethylase activity, J. Biol. Chem. 263 (1988) 1248-1254.
31. [31] Quesney-Huneeus V., Galick H.A., Siperstein M.D., Erickson S.K., Spencer T.A., Nelson J.A., The dual role of mevalonate in the cell cycle, J. Biol. Chem. 258 (1983) 378-385.
32. [32] Dabl C., Biemann H.P., Dabi J., A protein kinase antigenically related to pp60v-src possibly involved in yeast cell cycle control: positive in vivo regulation by sterol, Proc. Natl. Acad. Sci. USA 84 (1987) 4012-4016.
33. [33] Ramgopal M., Bloch K., Sterol synergism in yeast, Proc. Natl. Acad. Sci. USA 80 (1983) 712-715.
34. [34] Rodriguez R.J., Taylor F.R., Parks L.W., A requirement for ergosterol to permit growth of yeast sterol auxotrophs on cholestanol, Biochem. Biophys. Res. Commun. 106 (1982) 435-441.
35. [35] Green D.R., McGahon A., Martin S.J., Regulation of apoptosis by oncogenes, J. Cell. Biochem. 60 (1996) 33-38.
36. [36] Jones K.D., Couldwell W.T., Hinton D.R., Su Y., He S., Anker L., Law R.E., Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells, Biochem. Biophys. Res. Commun. 205 (1994) 1681-1687.
37. [37] Pérez-Sala D., Collado-Escobar D., Mollinedo E, Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease, J. Biol. Chem. 270 (1995) 6235-6242.
38. [38] Urem A.G., Vaoux D.L., Molecular and clinical aspects of apoptosis, Pharmacol. Ther. 72 (1996) 37-50.
39. [39] Polverino A.J., Patterson S.D., Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor, J. Biol. Chem. 272 (1997) 7013-7021.
40. [40] Zhao Y., Cao J., Ma H., Liu J., Apoptosis induced by tea polyphenols in HL-60 cells, Cancer Lett. 121 (1997) 163-167 .
41. [41] Pérez-Sala D., Gilbert B.A., Rando R.R., Canada F.J., Analogs of farnesylcysteine induce apoptosis in HL-60 cells, FEBS Lett. 426 (1998) 319-32.